Education
About Us
Working with TipRanks
Follow Us
Matthew Link Insider Profile
4 Followers
Matthew Link, President at NuVasive, holds 832.29K shares in Sight Sciences (Ticker: SGHT), holds 82.59K shares in NuVasive (Ticker: NUVA), holds ― shares in FibroBiologics, Inc. (Ticker: FBLG). Most recently, Matthew Link Sold ― shares of Sight Sciences on Jul 07, 2025 for an estimated value of $20.00K.
Profitable Transactions
2 out of 4 Profitable Transactions
Average Return
-42.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Matthew Link holds in companies
Most Profitable Insider Trade
The most profitable trade made by Matthew Link
Matthew Link's Trading History
NuVasive
Jun 10, 2020
―
Uninformative Sell
201.00K
$3.28M
Sight Sciences
Jul 07, 2025
CCO
Informative Sell
20.00K
$4.31M
FibroBiologics, Inc.
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Matthew Link's performance on stock
You May Also Like
Matthew Link insider profile FAQ
What is the percentage of profitable transactions made by Matthew Link?
The percentage of profitable transactions made by Matthew Link is 50%.
What is the average return per transaction made by Matthew Link?
The average return per transaction made by Matthew Link is -42.30%.
What stocks does Matthew Link hold?
Matthew Link holds: NUVA, SGHT, FBLG stocks.
What was Matthew Link’s latest transaction?
Matthew Link latest transaction was an Informative Sell of $20.00K.
What was Matthew Link's most profitable transaction?
Matthew Link’s most profitable transaction was an Informative Sell of SGHT stock on October 18, 2024. The return on the trade was 21.40%.
What is Matthew Link's role in NuVasive?
Matthew Link's role in NuVasive is President.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.